Physiotherapy of Axial Spondyloarthritis
PaxSpA
1 other identifier
interventional
38
1 country
2
Brief Summary
This protocol is for a pragmatic randomised controlled clinical trial (RCT) with a manual spinal mobilisation (MSM) intervention for patients with axial spondyloarthritis (axSpA), embedded in a Trials within Cohort (TwiCs) design. This trial might appear as a standardised RCT but there is a secondary element - an observational cohort the trial is embedded in. Trial A is the first (of possibly several) embedded pragmatic RCTs involving physiotherapy interventions that may identify therapies that will help improve outcomes for patients with axSpA. The investigators are seeking to improve outcomes for these patients by comparing different physiotherapy interventions in subsequent trials with standard of care (SoC) physiotherapy. Trial A will compare routine care vs routine care plus MSM physiotherapy attempting to answer the primary research question if MSM on patients with axSpA improves spinal mobility. In order to recruit patients and obtain outcomes for Trial A (n=70), the investigators will first recruit up to 300 axSpA patients receiving care at the Royal National Hospital for Rheumatic Diseases (RNHRD) in Bath into a cohort and observe their standard of care outcomes. This will allow to answer the cohort's research question of "How does SoC physiotherapy in patients with axSpA reflect in data collected routinely on outcomes of the disease?" Patients will be asked to consent to provide routine observational data on their wellbeing, be approached to take part in future trials of interventions which aim to improve outcomes for patients with axSpA, and not be approached unless they are offered the physiotherapy trial intervention. This highly pragmatic method of providing information and seeking consent replicates the informed consent procedures in routine care clinical settings. This study is aimed to last three years, with individual trials of 40-70 participants, ranging between three to six months duration of therapy intervention in addition to routine care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2021
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2020
CompletedFirst Posted
Study publicly available on registry
December 22, 2020
CompletedStudy Start
First participant enrolled
October 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2022
CompletedMay 16, 2024
April 1, 2024
9 months
November 16, 2020
May 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change of Spinal Mobility
Spinal mobility will be measured using inertial measurement unit sensors; Electro muscle stimulation (EMS) for muscle activity
baseline, 6 months, and follow-up at 12 months
Change of Spinal Mobility
Spinal mobility will be measured using the Bath Ankylosing Spondylitis Metrology Index (BASMI), scored on the mean of 5 items out of 0-10 (minimum value 0 maximum value 10), '0' being the best outcome and 10 being the worst outcome.
baseline, 3 months & 6 months, and follow-up at 12 months
Secondary Outcomes (5)
Change of Disease Activity
baseline, 3 month, 6 month, 12 month
Change of Functional limitation
baseline, 3 month, 6 month, 12 month
Change of Quality of Sleep (PROM)
baseline, 3 month, 6 month, 12 month
Change of Quality of Life (PROM)
baseline, 3 month, 6 month, 12 month
Change of Work Productivity (PROM)
baseline, 3 month, 6 month, 12 month
Study Arms (2)
Trial A - Intervention Group (manual mobilisation)
EXPERIMENTALParticipants will continue to receive routine care and 13 sessions of manual spinal mobilisation will be administered over a 6 months period to compare routine care vs routine care plus manual spine mobilisation physiotherapy.
Trial A - Control Group (routine care)
NO INTERVENTIONParticipants in control group will continue to receive routine care, and routine care measurements for axial spondyloarthritis will be taken at baseline, 3 months and 6 months plus follow up.
Interventions
Manual spinal mobilisation is a physiotherapy technique to improve spinal mobility by gently applying pressure manually on the each segmental vertebrae by hands-on treatment of a physiotherapist.
Eligibility Criteria
You may qualify if:
- Adult patients \> 18 years of age from the RUH Bath National Health Service (NHS) Foundation Trust Rheumatology service based at RNHRD who fulfil the modified New York Criteria or the Assessment of SpondyloArthritis international Society (ASAS) axial spondyloarthritis criteria giving written consent for participation.
You may not qualify if:
- Mechanical spinal disease causing red flag symptoms such as cauda equina syndrome
- Age \>70
- Pregnancy or breastfeeding
- Any malignancy
- Moderate coexistent other inflammatory conditions (such as rheumatoid arthritis, vasculitis or connective tissue disease, in order to minimise the effect particularly of inflammation). However clinical judgement might be used to judge the severity in some patients as to whether they are safe to be included in a trial.
- Any bridging syndesmophytes in the spine, to avoid the risk of causing vertebral fractures or instability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Sports Physiotherapy Calne
Calne, UK, SN11 9PR, United Kingdom
Royal National Hospital for Rheumatic Diseases (RNHRD)
Bath, Wiltshire, BA1 3NG, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jane Carter
Royal United Hospitals Bath NHS FT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Batch randomisation - computer generated
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 16, 2020
First Posted
December 22, 2020
Study Start
October 6, 2021
Primary Completion
June 20, 2022
Study Completion
July 30, 2022
Last Updated
May 16, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- Study Protocol and Consent form become available once recruitment has started. Clinical Study report becomes available on study conclusion.
- Access Criteria
- request access through Dr Raj Sengupta
Dr Sengupta has established a national and international panel of collaborators in the field of axial spondyloarthritis. We will therefore try to maintain our links with other experts in the field who are conducting cutting edge research in axSpA. Thus, the data collected as part of this study may be used in further research. Anonymised data may be shared with other researchers investigating non-pharmaceutical therapies in spondyloarthropathy. Requests for data would be evaluated on the basis of the research objectives of the intended project and any conflict of interests involved. If approved, recipients of data must forward copies of their protocol and ethics approval if appropriate to Dr Sengupta and the sponsor (RUH Bath NHS Foundation Trust Rheumatology service based at the RNHRD).